China NT Pharma Group Company Limited (HKG:1011)

Hong Kong · Delayed Price · Currency is HKD

0.4300

-0.0300 (-6.52%)

Jun 22, 2026, 3:38 PM HKT

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Agency Services	9.63M	374.00K	-		-	-
Agency Services Growth	2474.60%	-	-		-	-
Healthcare Related Services	14.53M	37.59M	-		-	-
Healthcare Related Services Growth	-61.34%	-	-		-	-
Proprietary Products Production and Sales	-	-	7.37M		226.70M	221.73M
Proprietary Products Production and Sales Growth	-	-	-		2.24%	44.48%
Total	24.16M	37.96M	7.37M		226.70M	221.73M
Total Growth	-36.36%	415.34%	-		2.24%	44.48%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Hong Kong	685.00K	36.33M	-		-	-
Hong Kong Growth	-98.11%	-	-		-	-
PRC (Excl. Hong Kong)	23.47M	1.63M	7.37M		226.70M	221.73M
PRC (Excl. Hong Kong) Growth	1341.83%	-77.90%	-		2.24%	44.48%
Total	24.16M	37.96M	7.37M		226.70M	221.73M
Total Growth	-36.36%	415.34%	-		2.24%	44.48%